| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:393697472:1634 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:393697472:1634?format=raw |
LEADER: 01634cam a22003378a 4500
001 011449259-X
005 20080508144523.0
008 070610s2007 enk b 001 0 eng
010 $a 2007024176
020 $a9780470319383 (alk. paper)
035 0 $aocn144568198
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRC694.3$b.A77 2007
060 10 $aWG 300$bA834m 2007
082 00 $a616.1/42$222
100 1 $aAskari, Arman.
245 10 $aManagement strategies in antithrombotic therapy /$cby Arman Askari and Adrian W. Messerli.
260 $aChichester ;$aHoboken, N.J. :$bJohn Wiley and Sons,$cc2007.
300 $axiv, 350$bill. (some col.)$c25 cm.
504 $aIncludes bibliographical references and index.
505 0 $aThrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia.
650 0 $aThrombolytic therapy.
650 0 $aThrombosis$xTreatment.
650 0 $aFibrinolytic agents.
650 12 $aCoronary Thrombosis$xdrug therapy.
650 12 $aHeart Diseases$xdrug therapy.
650 22 $aFibrinolytic Agents$xtherapeutic use.
700 1 $aMesserli, Adrian W.
988 $a20080425
906 $0OCLC